Item 7.01. Regulation FD Disclosure.
On May 3, 2022, Ms. Leslie Buttorff, Chief Executive Officer of Panacea Life
Sciences Holdings, Inc. made a presentation to certain members of the investment
community. A copy of such presentation is being furnished herewith as Exhibit
99.1 to this report.
The information in this Item 7.01 of this report, including the information in
the presentation attached as Exhibit 99.1 to this report, is furnished and shall
not be deemed “filed” for the purposes of Section 18 of the Securities Exchange
Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that
section. Furthermore, the information in Item 7.01 of this report, including the
information in the presentation attached as Exhibit 99.1 to this report, shall
not be deemed to be incorporated by reference in the filings of the registrant
under the Securities Act of 1933, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. Exhibit No. Exhibit 99.1 Investor Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses